AN ACT REQUIRING MEDICAID COVERAGE FOR FDA-APPROVED GENE THERAPIES TO TREAT SICKLE CELL DISEASE.

SB 1473 requires Medicaid to cover FDA-approved gene therapies used to treat sickle cell disease. This law directly affects Medicaid beneficiaries in the state diagnosed with sickle cell disease who would otherwise face barriers to accessing these advanced treatments. The key provision mandates that Medicaid must provide coverage for these specific therapies without requiring separate prior authorization for each treatment. The bill became law after being signed by the governor on June 23, 2025.